Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Theralase Hiring - Three Positions
View:
Post by Eoganacht on Oct 05, 2021 11:48am

Theralase Hiring - Three Positions

These positions have been on Indeed for 19 days, although there is nothing about them on the Theralase website.

Director of Clinical Development
$150,000 a year - Full-time, Permanent

Social and Digital Marketing Specialist
$65,000 a year - Full-time, Permanent

Web and Graphic Designer
$65,000 a year - Full-time, Permanent

 

 

Comment by Rumpl3StiltSkin on Oct 05, 2021 3:42pm
When the data comes in as expected these will be needed. :-)
Comment by BlueFranky on Oct 05, 2021 3:55pm
Or to further speculate, what would trigger the company to spend this money .. fill these particular roles ... at this particular moment in time? :-)
Comment by fredgoodwinson on Oct 05, 2021 4:07pm
Well it surely can`t be based on price sensitive information not yet disclosed to shareholders. 
Comment by Rumpl3StiltSkin on Oct 05, 2021 5:37pm
IMO just means the better numbers are still expected. :-)
Comment by Eoganacht on Oct 05, 2021 6:07pm
Theralase used to have a 3 member Clinical Research Team. Since the resignation of Shawn Shirazi there is no one left on the team. Arkady Mandel has been filling in but that's only temporary. They need to hire a Director of Clinical Development because they don't have anyone to fill that role. The mandate of the new COO is to boost the sales of the cold laser division and I think that' ...more  
Comment by Rumpl3StiltSkin on Oct 06, 2021 10:58am
Another possibility is the Covid piece. Perhaps they'd need these folk for getting the Covid vax/therapy news out there. Maybe they know this news is next???
Comment by 99942Apophis on Oct 06, 2021 11:56am
Sorry Rumpl3StiltSkin I tend to agree with Eoganacht that the obvious is the answer to the hiring and that is to simply replace those that quit Theralase's Clinical Research Team.
Comment by socksnblonds642 on Oct 06, 2021 1:06pm
Yup. And to boost laser sales. These positions help them move forward on both fronts. Absolutely nothing to do with Covid IMO. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250